A Guardian investigation into the U.S. overdose slowdown found that national declines masked sharp local disparities. Here's how the reporting team got the story.

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Building a multi-million dollar business in 90 days as a solo founder requires a “fractional and automated” mindset. You ...